This inventor holds 1 USPTO granted patent. Top assignee: Egyt Gyogyszervegyeszeti Gyar. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Erzsebet Fellner: Innovator in Pharmaceutical Technology
Introduction
Erzsebet Fellner is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of sustained release tablets. Her innovative approach has the potential to enhance the effectiveness of various medications.
Latest Patents
Erzsebet Fellner holds a patent for "Sustained release pharmaceutical tablets and process for the preparation." This invention provides a method for preparing sustained release tablets that include a hydrophilic polymer matrix, which constitutes at least 10% by weight of the composition. The matrix consists of a 5:1-1:5 weight to weight ratio mixture of a VP-VA copolymer and an acrylic acid homopolymer, cross-linked with polyallyl saccharose. The manufacturing method can be accomplished in two ways, either by creating a granulate containing the active ingredient or by supplementing the matrix granulate with the active ingredient. This latter method offers advantages in large-scale manufacturing and allows for modifications based on the properties of the active ingredients.
Career Highlights
Erzsebet is associated with Egyt Gyogyszervegyeszeti Gyar, where she applies her expertise in pharmaceutical development. Her work has led to advancements in the formulation of medications, making them more effective and easier to administer.
Collaborations
Erzsebet has collaborated with notable colleagues, including Zoltan Toth and Pal Fekete. These partnerships have contributed to her innovative work in the pharmaceutical industry.
Conclusion
Erzsebet Fellner's contributions to the field of pharmaceutical technology through her patent for sustained release tablets exemplify her commitment to innovation. Her work continues to impact the effectiveness of medication delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile